Last updated: Nov 17, 2026, 12:00 AM

Johnson & Johnson Exchange (NYSE, USD)

JNJ

278.70
-3.20 (-1.12%)
HealthcareDrug Manufacturers - General
Invest Today
Invest Today
1 year return (CAGR)
44.71%
3 year return (CAGR)
24.22%
5 year return (CAGR)
11.65%
10 year return (CAGR)
9.40%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
680.19B
Price/Sales
6.95
Ent value
779.17B
Price/Book
-
Div yield
1.90%
Growth years
58
Div growth
4.89%
FCF payout
95.35%
Trailing P/E
32.33
PEG
5.05
Forward P/E
24.32
EPS growth
14.90%

Business insight

iO Charts Blog

Meaning and Methodology of Fundamental Analysis (2025)

Read More

Segment Revenues ($M)

Loading...
Operations comments

In 21Q1 JNJ COVID-19 Vaccine authorized by U.S. FDA for emergency use

In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted emergency use listing by the World Health Organization

In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted conditional marketing authorization by European Commission

The company has not provided an official guidance for COVID-19 Vaccine revenues and margins for 2021

Ready to capitalize on Johnson & Johnson's growth potential?

Take the next step in your portfolio.

Invest Today

Geographic Revenues ($M)

Loading...